Bolt Biotherapeutics Inc. (BOLT)
NASDAQ: BOLT
· Real-Time Price · USD
5.15
-0.29 (-5.33%)
At close: Aug 15, 2025, 3:59 PM
5.23
1.55%
After-hours: Aug 15, 2025, 04:20 PM EDT
Bolt Biotherapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -11.04M | -15.94M | -15.18M | -21.2M | -10.81M | -17.9M | -16.26M | -18.06M | -16.98M | -20M | -21.76M | -22.66M | -23.68M | -27.16M | -23.39M | -23.59M | -24.45M |
Depreciation & Amortization | 399K | 426K | 440K | 457K | 458K | 497K | 462K | 458K | 467K | 462K | 439K | 408K | 357K | 361K | 304K | 256K | 272K |
Stock-Based Compensation | 709K | 1.18M | 1.1M | 2.83M | 2.3M | 2.07M | 2.33M | 2.35M | 2.48M | 2.12M | 2.14M | 2.39M | 2.92M | 2.14M | 2.23M | 2.02M | 2.11M |
Other Working Capital | n/a | -1.2M | -578K | 1.77M | -8.44M | 1.54M | -2.69M | 518K | -2.62M | -9.02M | -1.21M | 1.27M | -3.16M | -1.29M | 555K | 15.94M | -1.28M |
Other Non-Cash Items | n/a | 1.09M | 250K | -3K | 2.96M | 2.6M | 744K | 731K | -133K | 234K | 682K | 894K | 1.64M | 544K | 761K | 644K | 6.61M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -3.06M | -1.33M | -1.11M | n/a | n/a | n/a | n/a | n/a | 929K | 822K | 740K | 271K |
Change in Working Capital | n/a | -1.2M | -578K | 1.77M | -8.44M | 1.54M | -2.69M | 518K | -9.23M | -774K | 5.08M | -1.82M | -5.55M | 5.39M | 555K | 15.94M | -1.37M |
Operating Cash Flow | -13.37M | -14.43M | -13.97M | -16.14M | -16.75M | -14.27M | -16.75M | -15.11M | -23.4M | -17.95M | -13.45M | -20.79M | -24.31M | -17.79M | -18.73M | -3.99M | -16.56M |
Capital Expenditures | n/a | n/a | -41K | n/a | n/a | -6K | -165K | -32K | -3K | -184K | -735K | -429K | -605K | -562K | -1.01M | -703K | -58K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | 55.43M | -12.82M | -13.61M | -28.99M | -16.62M | n/a | 439K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -992K | -13.25M | -20.32M | -32.23M | -23.06M | -32.16M | -36.3M | -53.64M | -42.88M | -25.36M | -47.91M | -31.35M | -76.08M | -29.69M | -35.92M | -49.7M | -198.07M |
Sales Maturities Of Investments | 14.58M | 25.48M | 37.35M | 50.23M | 33.26M | 47.98M | 49.13M | 67.25M | 71.88M | 41.98M | 50.1M | 30.91M | 117.53M | 51.28M | 20.82M | 3.8M | 7.61M |
Other Investing Acitivies | 963K | n/a | 148K | n/a | 10.2M | n/a | 12.82M | 13.61M | 28.99M | 16.62M | 2.19M | -439K | 41.45M | 21.59M | -15.1M | -45.9M | -190.46M |
Investing Cash Flow | 14.55M | 12.23M | 17.14M | 18M | 10.2M | 15.81M | 12.66M | 13.58M | 28.99M | 16.43M | 1.45M | -868K | 40.84M | 21.03M | -16.11M | -46.6M | -190.52M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | -79K | 79K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | n/a | 29K | n/a | 79K | n/a | 106K | n/a | 147K | n/a | 144K | n/a | 252K | 107K | 495K | 185K | 13.41M | 297.02M |
Net Cash Flow | 1.19M | -2.17M | 3.17M | 1.94M | -6.55M | 1.65M | -4.09M | -1.39M | 5.59M | -1.37M | -12M | -21.4M | 16.64M | 3.73M | -34.65M | -37.18M | 89.94M |
Free Cash Flow | -13.37M | -14.43M | -14.01M | -16.14M | -16.75M | -14.27M | -16.91M | -15.14M | -23.4M | -18.14M | -14.19M | -21.22M | -24.92M | -18.36M | -19.74M | -4.69M | -16.62M |